US-based arms of national pharma companies Zydus Cadila and Alembic Pharmaceuticals are remembering one drug each from the US after getting complaints against the merchandise. “To date, Zydus Pharmaceuticals (USA) Inc hasn’t received any reports of adverse events associated with the item remember,” the firm said. The business has notified its distributors and clients by email and FedEx overnight courier service and is organizing for the return of recalled Acyclovir Sodium Injection, 50 mg/mL lots. Hospitals that have the item that has been remembered should cease using it immediately and telephone the firm’s recall coordinating center, it included. “To date, Alembic Pharmaceuticals Ltd has not received any reports of adverse events related to the recall,” it added.
Alembic Pharmaceuticals Ltd is advising its retailers and suppliers via a letter and can be organizing for the sake of the recalled lot, the business said. The product has been recalled because of an industry criticism received that said that one bottle branded as 30-count Telmisartan pills, USP, 20 mg wrongly contained 30 pills of Telmisartan, USP, 40mg, it included. Patients who might be on a dual dose of Telmisartan for a lengthy time period may experience reduced blood pressure, worsening of kidney function, or even an elevation of potassium that could be life-threatening, the business said.
Administration of crystallized Acyclovir Sodium Injection, 50 mg/mL includes a possibility of life-threatening adverse effects, it included.